News

FDA approves ketamine product for surgical pain management

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

FDA's new expert panels are rife with financial conflicts and fringe views

When the Food and Drug Administration needs outside guidance, it normally turns to a trusted source: a large roster of expert ...
MedPage Today3h

Semaglutide Gets FDA Greenlight for MASH

The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...
Medscape13h

FDA Warns of Future Action on Animal-Derived Thyroid Drugs

US regulators sent seemingly mixed messages this month about the outlook for animal-derived, or desiccated, thyroid medicines ...

Novo Nordisk's Wegovy receives FDA approval to treat serious liver disease

CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on Novo Nordisk, what new FDA approval on its ...
Medscape3h

FDA Approves First-in-Class Drug for Fibromyalgia

Sublingual cyclobenzaprine (Tonmya), a nonopioid treatment for adults with fibromyalgia, targets nonrestorative sleep, a root ...

Stealth resubmits rare disease drug to FDA

The biotech, which cut jobs following the rejection in May of its Barth syndrome therapy, claimed it has addressed the agency ...
Healio5h

FDA warns whipped, mousse sunscreen formulations may be ineffective

The FDA’s recent issue of five warning letters to brands illegally marketing whipped, mousse and foam sunscreen products ...
FOX 13 Tampa Bay7h

Orange juice sugar cuts proposed by FDA to help citrus growers: What it means for you

The U.S. Food and Drug Administration (FDA) is proposing an update to a decades-old orange juice rule that could give ...
STAT5h

Conflicts among CDC and FDA vaccine panel members are not as numerous as you think, study finds

Robert F. Kennedy Jr. has said the CDC's vaccine advisory board was rife with conflicts of interest. A new analysis shows ...
Fierce Biotech6h

Stealth Bio submits third FDA application for rare disease candidate

After an FDA rejection in May, Stealth BioTherapeutics has resubmitted a new drug application for its investigational ...

Birth control use is up since FDA approved over-the-counter pill

A new study shows access to birth control has increased following the FDA's approval of an over-the-counter birth control pill. In the two years since the pill went on the market, there's a 31.8% ...